XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2021
Summary of Stock option and restricted stock activity

A summary of stock option and restricted stock activity under the 2008 Plan and Inducement Grants during the six months ended June 30, 2021 and 2020 is presented below:

(in thousands)

Options

Inducement Grants

RSAs

Outstanding at December 31, 2019

 

757

192

Granted

 

7

261

Options Exercised/RSAs Vested

 

(8)

(121)

 (1)

Forfeited

 

(13)

(17)

Expired

 

Outstanding at June 30, 2020

 

743

315

Outstanding at December 31, 2020

 

756

180

352

Granted

 

84

61

457

Options Exercised/RSAs Vested

 

(5)

(111)

 (2)

Forfeited

 

(58)

(53)

Expired

 

Outstanding at June 30, 2021

 

777

241

645

(1)Includes 43 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $1.6 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
(2)Includes 25 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $0.8 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
Employee Stock Purchase Plan 2016 [Member]  
Summary of allocated expense

(in thousands)

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2021

    

2020

    

2021

    

2020

    

Cost of sales

$

4

$

7

$

8

$

11

Research and development

 

6

 

12

 

11

 

19

Selling, general, and administrative

 

23

 

38

 

46

 

56

$

33

$

57

$

65

$

86

Stock Incentive Plan 2008 [Member]  
Summary of allocated expense

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

    

Cost of sales

$

2

$

33

$

2

$

59

Research and development

 

149

 

146

 

263

 

333

Selling, general, and administrative

 

2,660

 

5,500

 

4,383

 

7,682

$

2,811

$

5,679

$

4,648

$

8,074